This inventor holds 2 USPTO granted patents and 2 published patent applications and 1 EPO patent. Top assignees: University of Missouri, Voyager Therapeutics, Inc.. Active years: 2015-2024.
Company Filing History:
Years Active: 2015-2024
Title: Innovations and Contributions of Joan R. Coates
Introduction
Joan R. Coates is a notable inventor based in Columbia, MO (US). She has made significant contributions to the field of medical science, particularly in the treatment of neurodegenerative diseases. With a total of 2 patents, her work has garnered attention for its innovative approaches and potential impact on patient care.
Latest Patents
One of her latest patents focuses on the treatment of amyotrophic lateral sclerosis (ALS). This invention relates to adeno-associated viruses (AAVs) encoding a SOD1 targeting polynucleotide, which may be utilized to treat ALS and canine degenerative myelopathy (DM). Another patent involves the design of an animal kennel for scientific examination. This kennel comprises front, rear, top, bottom, and opposite side walls that collectively define a cavity. Notably, a portion of the cavity has a horizontal cross-section that is bordered by the front, rear, and opposite side walls, with the front portion being narrower than the rear portion. The majority of the kennel's walls are formed from a material that is translucent and radiolucent, enhancing its utility in scientific research.
Career Highlights
Joan has worked with esteemed organizations such as the University of Missouri and Voyager Therapeutics, Inc. Her experience in these institutions has allowed her to develop and refine her innovative ideas, contributing to advancements in medical technology.
Collaborations
Throughout her career, Joan has collaborated with notable colleagues, including Teresa Lever and Mitchell Allen. These partnerships have fostered a collaborative environment that encourages the exchange of ideas and expertise.
Conclusion
Joan R. Coates exemplifies the spirit of innovation in the field of medical science. Her patents and collaborations reflect her commitment to improving treatment options for patients with neurodegenerative diseases. Her work continues to inspire future advancements in the field.

